EUVIMEDEUVIMED entdecken
Crossref

High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor

Xiuxiu Ma, Meng Wang, Fan Wang, Jiao Li, Zhengguang Zhang, Jiapeng Zhu, Bing Liu

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2023.149284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Xiuxiu Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China. Hauptthemen laut MEDLINE: Nuclear Proteins, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inhibition of BRD4 bromodomain is an effective therapeutic strategy for a variety of diseases in which BRD4 are implicated. Herein, we identified a small-molecule BRD4 inhibitor hit named compound 3 using high-throughput screening. The 1.6 Å resolution co-crystal structure confirmed that the compound occupies the KAc recognition pockets of BRD4 by forming key hydrogen bonds with Asn140 and engaging in hydrophobic interactions, thus impedes the binding of acetylated lysine to BRD4. These findings suggest compound 3 can be a lead compound to develop a structurally novel BRD4 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsCell Cycle ProteinsTranscription FactorsHigh-Throughput Screening AssaysProtein DomainsStructure-Activity Relationship

Stichwörter der Autor:innen

BRD4Inhibitor precursorX-ray crystallography

Substanzen

Nuclear ProteinsCell Cycle ProteinsTranscription Factors

Autor:innen und Institutionen

  • School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
  • School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Schoo…
  • School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China. Electronic address: bingliu@njucm.edu.cn.

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Ma, X., Wang, M., Wang, F., Li, J., Zhang, Z., Zhu, J., & Liu, B. (2024). High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149284

Vancouver

Ma X, Wang M, Wang F, Li J, Zhang Z, Zhu J, et al. High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2023.149284

BibTeX
@article{Ma2024,
  author = {Ma, Xiuxiu and Wang, Meng and Wang, Fan and Li, Jiao and Zhang, Zhengguang and Zhu, Jiapeng and Liu, Bing},
  title = {High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2023.149284}
}
Kostenlos starten →